Cardiac Biomarkers Testing Market Global Analysis and Forecast Report 2019 to 2026 | Industry Key Players - Roche Diagnostics, Abbott Laboratories, Siemens Healthcare, Bio-Rad Laboratories, BioMerieux, PerkinElmer, Tosoh Corp., Danaher Corp.,

The report on “Cardiac Biomarkers Testing Market” will help Major Players and the new entrants to understand scrutinize the market in detail. This information will encourage the Major Players to decide their business strategy and achieve proposed business aims.

The global cardiac biomarker market generated $7,638 million in 2018, and is projected to reach $18,232 million by 2026, growing at a CAGR of 11.4%. Cardiac biomarkers are protein-based traceable substances used as an indicator of biologic state as well as for diagnostic and prognostic purposes associated with heart. The prevention of cardiac diseases by monitoring heart conditions via cardiac biomarker testing is the profound approach for obtaining rapid results for immediate diagnosing and treatment. Cardiac biomarkers are used as risk stratification for various cardiovascular diseases (CVDs), which include myocardial infraction, congestive heart failure, acute coronary syndrome (ACS), and others. The cardiac biomarkers that are widely used as an integrated diagnostic approach for CVDs include CK-MB, troponin I and T, myoglobin, BNPs, IMA, and others. The global cardiac biomarkers testing market has witnessed a greater demand over the past five to six years.

Get PDF sample copy: https://www.premiummarketinsights.com/sample/AMR00015593

Companies Covered in this Report are:
- Roche Diagnostics
- Abbott Laboratories
- Siemens Healthcare
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- BioMerieux
- PerkinElmer Inc.
- Tosoh Corporation
- Danaher Corporation
- Thermo Fisher Scientific

The ability of cardiac markers for accurate and rapid prediction of heart failure after the onset of chest pain acts as a key factor that boosts the growth of the global cardiac market. In addition, promising features such as high accuracy, quick outcomes, and economic pricing of cardiac point of care (POC) testing drive the market growth. To keep the momentum of cardiac marker tests, key manufacturers offer customized solutions, thus propelling the growth of the market. The commercial application of multi-menu options for cardiac testing using different combinations of cardiac biomarkers and target-oriented solutions serves as the key opportunity for market expansion. However, limited specificity in some cases and side effects such as skeletal muscle injury restrain the growth of the cardiac biomarkers testing market.

The global cardiac biomarker market is segmented based on type, application, location of testing, and region. By type, the market is fragmented into myocardial muscle creatine kinase (CK-MB), troponins (T and I), myoglobin, brain natriuretic peptide (BNPs) or NT-proBNP, ischemia modified albumin (IMA), and others. Depending on application, it is categorized into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis, and others. By location of testing, it is bifurcated into point of care testing and laboratory testing. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
This report highlights the market dynamics to understand the global cardiac biomarker market and capitalize on the prevailing opportunities.
Quantitative analysis of the current market and forecasts assists stakeholders to design business strategies accordingly.
Porter's five forces analysis examines the competitive market structure and provides a deeper understanding of the influencing factors for entry and expansion.
Pin-point analysis of geographical segments offers identification of most profitable segments to capitalize on.

To Purchase This report details at: https://www.premiummarketinsights.com/buy/AMR00015593

KEY MARKET SEGMENTS
By Type
Myocardial Muscle Creatine Kinase (CK-MB)
Troponins (T and I)
Myoglobin
Brain Natriuretic Peptide (BNPs) or NT-proBNP
Ischemia-modified Albumin (IMA)
Others

By Application
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others

By Location of Testing
Point of Care Testing
Laboratory Testing

By Region
North America
- U.S.
- Canada
- Mexico

Europe
- Germany
- France
- Spain
- Italy
- UK
- Rest of Europe

Asia-Pacific
- Australia
- Japan
- India
- China
- Rest of Asia-Pacific

LAMEA
- Latin America
- Middle East
- Africa

The other players in the value chain include (profiles not included in the report):
- Randox Laboratories
- Johnson and Johnson
- Olympus Corporation
- BG Medicines
- ACS Biomarker B.V.
- Cavadis Biomedical.

Contact Us:
Name: Sameer Joshi
Organization: Premium Market Insights
Email: sales@premiummarketinsights.com
Phone: +1-646-491-9876

About Premium Market Insights:
Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.

This release was published on openPR.